X0206 3 2021-09-14 0 0001863127 Tyra Biosciences, Inc. TYRA 0001711463 Harris Todd C/O TYRA BIOSCIENCES, INC. 2656 STATE STREET CARLSBAD CA 92008 1 1 0 0 Chief Executive Officer Common Stock 1662336 D Series A Preferred Stock 0.00 Common Stock 34007 D Stock Option (Right to Buy) 2.25 2031-03-09 Common Stock 178202 D Stock Option (Right to Buy) 2.25 2031-03-09 Common Stock 429012 D Includes 464,088 shares subject to repurchase by us, which are subject to vesting. The shares of Series A Preferred Stock are convertible, at any time, at the holder's election, to shares of the Issuer's common stock at a ratio of 1-for-2.5974. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock will automatically convert to shares of the Issuer's common stock at a ratio of 1-for-2.5974. The Series A Preferred Stock has no expiration date. 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date. Exhibit List: Exhibit 24 - Power of Attorney /s/ John Healy, Attorney-in Fact 2021-09-14